Renato Simonetti

Renato Simonetti

Auto-generated profile, based on publicly available information

Renato Simonetti

Stroke Unit, Neurology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain (A.M.-O., M.R.-G., M. Requena, M.O.-G., J.M., A.G.-T., R.S., F.R., M. Ribo)

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Stroke: Vascular and Interventional Neurology
Verified
Journal Article
Open access
AMAne Murillo-Olaizola
Ane Murillo-Olaizola
MRMarc Rodrigo-Gisbert
Marc Rodrigo-Gisbert
MRManuel Requena
Manuel Requena
ABAnderson Brito-Alvarado
Anderson Brito-Alvarado
FDFrancesco Diana
Francesco Diana
MRMarc Ribó
Marc Ribó
BACKGROUND: Recent randomized controlled trials of endovascular treatment (EVT) for distal and medium vessel occlusion (DMVO) stroke did not demonstrate clinical benefit over best medical therapy and suggested potential safety concerns. We aimed to compare baseline characteristics of patients with DMVO stroke enrolled in these trials with those treated with EVT in routine clinical practice (RCP). METHODS: We conducted a retrospective cohort study of a prospectively recorded dual-center database including all consecutive patients with an acute ischemic stroke due to isolated primary DMVO (distal or nondominant M2, M3, A1, A2, A3, P1, P2) between January 2022 and July 2024 who fulfilled trials inclusion/exclusion criteria. Both centers participated in the DMVO trials during the study period. Patients were categorized in 2 groups: those who underwent EVT under RCP (RCP group) versus those randomized in a trial for DMVO stroke (clinical trial, computed tomography group). The 2 groups were evaluated and compared based on demographic, clinical, imaging, and treatment characteristics. RESULTS: Among 182 patients (median age, 79 years; interquartile range [IQR], 69–86; 46.2% female), 53 (29.1%) were included in a trial, and 129 (70.9%) were treated in RCP. Compared with RCP patients, those in the computed tomography group presented lower baseline stroke severity (median NIHSS, 5 [IQR, 4–7] versus 10 [IQR,7–15]; P <0.001), smaller admission hypoperfusion volumes (27 mL [IQR, 16–42] versus 48 mL [IQR, 24–70]; P <0.001) and a trend toward more vascular risk factors (2, [IQR, 1–3] versus 1 [1–2] in RCP patients; P =0.062) was observed. Angiographic outcomes among patients undergoing EVT trended toward higher successful reperfusion in the RCP group (87.6% versus 72.0%; P =0.051). CONCLUSIONS: In our study, conducted at 2 centers participating in DMVO clinical trials, randomized patients presented milder clinical severity and smaller hypoperfusion areas compared with those treated in daily practice, suggesting a potential selection bias. Our findings highlight the importance of consecutive recruitment in future DMVO trials to clarify the role of EVT.

20 February 2024 in Journal of Clinical Nursing
Verified
Journal Article
Open access
OPOlalla Pancorbo
Olalla Pancorbo
ESEstela Sanjuan
Estela Sanjuan
MRMaría Teresa Rodríguez‐Samaniego
María Teresa Rodríguez‐Samaniego
OMOlga Miñarro
Olga Miñarro
RSRenato Simonetti
Renato Simonetti
DRDavid Rodriguez‐Luna
David Rodriguez‐Luna
Aim: To evaluate the impact of nurse care changes in implementing a blood pressure management protocol on achieving rapid, intensive and sustained blood pressure reduction in acute intracerebral haemorrhage patients.Design: Retrospective cohort study of prospectively collected data over 6 years.Methods: Intracerebral haemorrhage patients within 6 h and systolic blood pressure ≥ 150 mmHg followed a rapid (starting treatment at computed tomography suite with a target achievement goal of ≤60 min), intensive (target systolic blood pressure < 140 mmHg) and sustained (maintaining target stability for 24 h) blood pressure management plan. We differentiated six periods: P1, stroke nurse at computed tomography suite (baseline period); P2, antihypertensive titration by stroke nurse; P3, retraining by neurologists; P4, integration of a stroke advanced practice nurse; P5, after COVID‐19 impact; and P6, retraining by stroke advanced practice nurse. Outcomes included first‐hour target achievement (primary outcome), tomography‐to‐treatment and treatment‐to‐target times, first‐hour maximum dose of antihypertensive treatment and 6‐h and 24‐h systolic blood pressure variability.Results: Compared to P1, antihypertensive titration by stroke nurses (P2) reduced treatment‐to‐target time and increased the rate of first‐hour target achievement, retraining of stroke nurses by neurologists (P3) maintained a higher rate of first‐hour target achievement and the integration of a stroke advanced practice nurse (P4) reduced both 6‐h and 24‐h systolic blood pressure variability. However, 6‐h systolic blood pressure variability increased from P4 to P5 following the impact of the COVID‐19 pandemic. Finally, compared to P1, retraining of stroke nurses by stroke advanced practice nurse (P6) reduced tomography‐to‐treatment time and increased the first‐hour maximum dose of antihypertensive treatment.Conclusion: Changes in nursing care and continuous education can significantly enhance the time metrics and blood pressure outcomes in acute intracerebral haemorrhage patients.Reporting Method: STROBE guidelines.Patient and Public Contribution: No Patient or Public Contribution.

1 June 2025 in Stroke
Verified
Journal Article
Closed access
DRDavid Rodriguez-Luna
David Rodriguez-Luna
OPOlalla Pancorbo
Olalla Pancorbo
MRManuel Requena
Manuel Requena
RSRenato Simonetti
Renato Simonetti
MRMarc Rodrigo-Gisbert
Marc Rodrigo-Gisbert
MRMarc Ribó
Marc Ribó
BACKGROUND: Shorter times to initiate antihypertensive and anticoagulation reversal treatments enhance their benefits in acute intracerebral hemorrhage (ICH). Improving workflows to optimize time performance metrics is strongly advocated. We aimed to evaluate the impact of direct transfer to angiography suite (DTAS) on time metrics for antihypertensive and anticoagulation reversal treatments in patients with stroke with suspected large vessel occlusion whose final diagnosis was ICH. METHODS: We conducted a single-center, retrospective, observational cohort study using prospectively collected data from patients with ICH 4 and in-hospital National Institutes of Health Stroke Scale score >10) followed either direct transfer to computed tomography (DTCT) or DTAS protocol based on angiosuite availability. We compared door-to-needle times for initiating antihypertensive (primary outcome) and anticoagulation reversal treatments between both workflows. RESULTS: Among 220 patients with ICH (mean age, 73.0±13.6 years; 131 [59.5%] male), 199 (90.5%) followed the DTCT protocol and 21 (9.5%) followed the DTAS protocol. Door-to-imaging time was shorter in the DTCT group than in the DTAS group (11 [7–17] versus 15 [12–20] minutes; P =0.013). Antihypertensive treatment was initiated in 168 (76.4%) patients, with the DTCT group having shorter door-to-needle times (20 [15–26] versus 30 [18–40] minutes; P =0.002). The anticoagulation reversal was administered to 34 (87.2%) of 39 anticoagulated patients, with the DTCT group achieving shorter door-to-needle times (28 [22–38] versus 58 [39–78] minutes; P =0.047). Time-to-event analysis showed that the DTCT group had a higher probability of initiating antihypertensive ( P =0.001) and anticoagulation reversal ( P =0.014) treatments sooner compared with the DTSA group. CONCLUSIONS: Patients with ICH following the DTAS workflow, without tailored actions, present longer door-to-needle times to initiate antihypertensive and anticoagulation reversal treatments compared with those following the DTCT workflow protocol.

19 November 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
RSRenato Simonetti
Renato Simonetti
PCPere Canals
Pere Canals
JRJesus David Gonzalez Riveros
Jesus David Gonzalez Riveros
MAManuel Alanís-Bernal
Manuel Alanís-Bernal
OPOlalla Pancorbo
Olalla Pancorbo
DRDavid Rodriguez-Luna
David Rodriguez-Luna
Introduction: Intracerebral haemorrhage (ICH) is associated with high early mortality and morbidity. Early clinical deterioration is common and influenced by haematoma expansion, which can occur within the first hours after symptom onset. Transcranial duplex sonography (TCD) is a rapid, non-invasive tool that may aid in early ICH detection but is highly operator-dependent. Artificial intelligence (AI)-based analysis of ultrasound images has shown promise in other fields but has not yet been validated in acute ICH. Methods and analysis: This is a single-centre, prospective feasibility study involving 500 patients with acute ischaemic and haemorrhagic stroke (<48 hours from onset), with a 1:4 haemorrhagic-to-ischaemic ratio reflecting population prevalence. Patients with infratentorial haemorrhage will be excluded. Once computed tomography (CT) confirms the diagnosis, TCD will be performed, and coded sonographic data will be collected. AI models, including pre-trained convolutional neural networks and transformer-based architectures, will be fine-tuned using sonographic images labelled by CT diagnosis. The model will aim to classify binary outputs: ‘ICH suspected’ versus ‘No ICH’. Clinical, radiological and temporal variables will be recorded to evaluate associations with outcomes. Ethics and dissemination: Ethical approval has been obtained. Informed consent will be collected. Data will be coded and stored securely. Results will be disseminated through peer-reviewed journals and conferences. Trial registration number: Not applicable at this stage (observational AI study).

1 February 2026 in Stroke
Verified
Journal Article
Closed access
CMCarmen Montalvo
Carmen Montalvo
AGAlvaro Garcia-Tornel
Alvaro Garcia-Tornel
MOMarta Olive-Gadea
Marta Olive-Gadea
MRMarc Rodrigo-Gisbert
Marc Rodrigo-Gisbert
MRManuel Requena
Manuel Requena
MRMarc Ribó
Marc Ribó
BACKGROUND: The influence of socioeconomic deprivation on outcomes in ischemic stroke patients treated with thrombectomy remains unclear. METHODS: We analyzed 6219 patients with ischemic stroke treated with thrombectomy between 2016 and 2023 in Catalonia, Spain. Socioeconomic deprivation was defined at the health care service area level (n=378) as the proportion of inhabitants with an annual income below $21 000. The adjusted absolute difference in the proportion of patients achieving good functional outcome (90-day modified Rankin Scale score of 0–2) between the least and most deprived areas (fifth versus 95th percentile) was estimated based on mixed effects modeling. Secondary outcomes included mortality at 90 days, 24-hour National Institutes of Health Stroke Scale score, complete reperfusion, and onset to arterial puncture time. Analyses were stratified by reference center location—Barcelona metropolitan region (fully covered by thrombectomy-capable centers) and Catalonia provincial region (dispersed population with varying center capabilities, including 3 thrombectomy-capable centers). The contribution of deprivation to between-center variance was estimated using a between-within effects model. RESULTS: Patients from most deprived areas were less likely to achieve functional independence in metropolitan (adjusted absolute difference, 7.4% [95% CI, 2.1%–12.7%]; P <0.01) than provincial (adjusted absolute difference, 10% [95% CI, 2.8%–17.2%]; P <0.01) regions. Mortality rate, complete reperfusion, and 24-hour National Institutes of Health Stroke Scale score did not differ between areas, whereas time from onset to thrombectomy was delayed in most deprived areas of the provincial region (least deprived 226 minutes [95% CI, 196–256] versus most deprived 272 minutes [95% CI, 247–298], difference 46 minutes [95% CI, 3–90]; P =0.02). Average center-level socioeconomic deprivation explained a substantial proportion of between-center variability in good functional outcomes, particularly in the metropolitan region. CONCLUSIONS: Socioeconomic deprivation is a major determinant of poor functional outcomes in patients with stroke undergoing endovascular thrombectomy in Catalonia, Spain, explaining a substantial proportion of between-center differences in outcomes. This disparity may be partially attributed to delays in acute treatment; however, postacute care factors should be evaluated as key contributors.

6 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
ABAdriano Bonura
Adriano Bonura
JJJesus Juega
Jesus Juega
CMClaudia Meza
Claudia Meza
JEJordi Kühne Escolà
Jordi Kühne Escolà
MMMarian Muchada
Marian Muchada
RFRuben Fernandez-Galera
Ruben Fernandez-Galera
Background and Purpose: Embolic stroke of undetermined source (ESUS) emains a major diagnostic challenge in vascular neurology, as a substantial proportion of patients lack an identifiable embolic source despite standardized diagnostic workup. The failure of empiric anticoagulation strategies highlights the need for individualized, mechanism-oriented risk stratification. We aimed to develop a machine learning–based framework to estimate the most likely embolic source in ESUS using routinely available clinical data. Methods: We retrospectively analyzed consecutive ESUS patients admitted to the Stroke Unit of Vall d’Hebron Hospital between 2020 and 2024. Three supervised machine learning models (XGBoost, Random Forest, and regularized logistic regression) were trained to independently predict the presence of left atrial enlargement (LAE), left ventricular dysfunction or akinesia (LVD), and complex aortic plaques (AP), based on demographic, clinical, laboratory, and imaging variables available at diagnosis. Model interpretability was assessed using permutation importance and SHAP analyses. Results: Among 1,741 ESUS patients (mean age 71.5±14.6 years; 48.3% women), LAE was present in 40.5%, AP in 11.0%, and LVD in 6.5%. XGBoost achieved the best overall performance across targets (PR-AUC: 0.71 for LAE, 0.29 for AP, 0.44 for LVD). Distinct and biologically coherent risk profiles emerged. LAE was driven by older age, elevated NT-proBNP, higher stroke severity, and a non-linear association with cholesterol. AP was associated with advanced age and traditional vascular risk factors. LVD showed a cardiomyopathic pattern characterized by elevated NT-proBNP, younger age, male sex, and severe strokes. Conclusions: A machine learning–based approach can provide probabilistic, mechanism-oriented stratification in ESUS, capturing non-linear interactions among routinely available variables. This framework may support clinicians in prioritizing targeted diagnostic pathways and tailoring secondary prevention strategies, pending external validation.